150 related articles for article (PubMed ID: 31643059)
21. ADC Analysis by Hydrophobic Interaction Chromatography.
Fleming R
Methods Mol Biol; 2020; 2078():147-161. PubMed ID: 31643055
[TBL] [Abstract][Full Text] [Related]
22. Detection and Characterization of In Vitro Payload-Containing Catabolites of Noncleavable Antibody-Drug Conjugates by High-Resolution Mass Spectrometry and Multiple Data Mining Tools.
Cai T; Shi L; Guo H; Li R; Cao W; Shen L; Zhu M; Tao Y
Drug Metab Dispos; 2023 May; 51(5):591-598. PubMed ID: 36707253
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP.
Matsuda Y; Robles V; Malinao MC; Song J; Mendelsohn BA
Anal Chem; 2019 Oct; 91(20):12724-12732. PubMed ID: 31478640
[TBL] [Abstract][Full Text] [Related]
24. Cutting-edge multi-level analytical and structural characterization of antibody-drug conjugates: present and future.
Beck A; D'Atri V; Ehkirch A; Fekete S; Hernandez-Alba O; Gahoual R; Leize-Wagner E; François Y; Guillarme D; Cianférani S
Expert Rev Proteomics; 2019 Apr; 16(4):337-362. PubMed ID: 30706723
[TBL] [Abstract][Full Text] [Related]
25. Catabolism of antibody drug conjugates and characterization methods.
Shadid M; Bowlin S; Bolleddula J
Bioorg Med Chem; 2017 Jun; 25(12):2933-2945. PubMed ID: 28438386
[TBL] [Abstract][Full Text] [Related]
26. Online coupling of analytical hydrophobic interaction chromatography with native mass spectrometry for the characterization of monoclonal antibodies and related products.
Yan Y; Xing T; Wang S; Daly TJ; Li N
J Pharm Biomed Anal; 2020 Jul; 186():113313. PubMed ID: 32371326
[TBL] [Abstract][Full Text] [Related]
27. Intact quantitation of cysteine-conjugated antibody-drug conjugates using native mass spectrometry.
Li Y; Wang Y; Shenoy VM; Niu S; Jenkins GJ; Sarvaiya H
Rapid Commun Mass Spectrom; 2024 Aug; 38(15):e9774. PubMed ID: 38812280
[TBL] [Abstract][Full Text] [Related]
28. Rapid Analysis of Reduced Antibody Drug Conjugate by Online LC-MS/MS with Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
Larson EJ; Zhu Y; Wu Z; Chen B; Zhang Z; Zhou S; Han L; Zhang Q; Ge Y
Anal Chem; 2020 Nov; 92(22):15096-15103. PubMed ID: 33108180
[TBL] [Abstract][Full Text] [Related]
29. A size exclusion-reversed phase two dimensional-liquid chromatography methodology for stability and small molecule related species in antibody drug conjugates.
Li Y; Gu C; Gruenhagen J; Zhang K; Yehl P; Chetwyn NP; Medley CD
J Chromatogr A; 2015 May; 1393():81-8. PubMed ID: 25818558
[TBL] [Abstract][Full Text] [Related]
30. Bioanalytical assay strategies for the development of antibody-drug conjugate biotherapeutics.
Kaur S; Xu K; Saad OM; Dere RC; Carrasco-Triguero M
Bioanalysis; 2013 Jan; 5(2):201-26. PubMed ID: 23330562
[TBL] [Abstract][Full Text] [Related]
31. Native Reversed-Phase Liquid Chromatography: A Technique for LCMS of Intact Antibody-Drug Conjugates.
Chen TH; Yang Y; Zhang Z; Fu C; Zhang Q; Williams JD; Wirth MJ
Anal Chem; 2019 Feb; 91(4):2805-2812. PubMed ID: 30661356
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the Primary Structure of Cysteine-Linked Antibody-Drug Conjugates Using Capillary Electrophoresis with Mass Spectrometry.
Saadé J; Gahoual R; Beck A; Leize-Wagner E; François YN
Methods Mol Biol; 2020; 2078():263-272. PubMed ID: 31643063
[TBL] [Abstract][Full Text] [Related]
33. Antibody Subunit LC-MS Analysis for Pharmacokinetic and Biotransformation Determination from In-Life Studies for Complex Biotherapeutics.
Kellie JF; Pannullo KE; Li Y; Fraley K; Mayer A; Sychterz CJ; Szapacs ME; Karlinsey MZ
Anal Chem; 2020 Jun; 92(12):8268-8277. PubMed ID: 32392410
[TBL] [Abstract][Full Text] [Related]
34. High-Resolution Capillary Zone Electrophoresis with Mass Spectrometry Peptide Mapping of Therapeutic Proteins: Peptide Recovery and Post-translational Modification Analysis in Monoclonal Antibodies and Antibody-Drug Conjugates.
Dada OO; Zhao Y; Jaya N; Salas-Solano O
Anal Chem; 2017 Nov; 89(21):11236-11242. PubMed ID: 28984442
[TBL] [Abstract][Full Text] [Related]
35. Middle-Down Multi-Attribute Analysis of Antibody-Drug Conjugates with Electron Transfer Dissociation.
Chen B; Lin Z; Zhu Y; Jin Y; Larson E; Xu Q; Fu C; Zhang Z; Zhang Q; Pritts WA; Ge Y
Anal Chem; 2019 Sep; 91(18):11661-11669. PubMed ID: 31442030
[TBL] [Abstract][Full Text] [Related]
36. Unconjugated payload quantification and DAR characterization of antibody-drug conjugates using high-resolution MS.
Grafmuller L; Wei C; Ramanathan R; Barletta F; Steenwyk R; Tweed J
Bioanalysis; 2016 Aug; 8(16):1663-78. PubMed ID: 27487385
[TBL] [Abstract][Full Text] [Related]
37. A method to directly analyze free-drug-related species in antibody-drug conjugates without sample preparation.
de Mel N; Mulagapati SHR; Cao M; Liu D
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 May; 1116():51-59. PubMed ID: 30981182
[TBL] [Abstract][Full Text] [Related]
38. LC/MS/MS Bioanalysis of Protein-Drug Conjugates-The Importance of Incorporating Succinimide Hydrolysis Products.
Shi C; Goldberg S; Lin T; Dudkin V; Widdison W; Harris L; Wilhelm S; Jmeian Y; Davis D; O'Neil K; Weng N; Jian W
Anal Chem; 2018 Apr; 90(8):5314-5321. PubMed ID: 29589741
[TBL] [Abstract][Full Text] [Related]
39. Approaches to Interchain Cysteine-Linked ADC Characterization by Mass Spectrometry.
Valliere-Douglass JF; Hengel SM; Pan LY
Mol Pharm; 2015 Jun; 12(6):1774-83. PubMed ID: 25474122
[TBL] [Abstract][Full Text] [Related]
40. Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry.
Xu K; Liu L; Saad OM; Baudys J; Williams L; Leipold D; Shen B; Raab H; Junutula JR; Kim A; Kaur S
Anal Biochem; 2011 May; 412(1):56-66. PubMed ID: 21216214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]